Ohne Autorenangabe:
1. Bundesamt für Veterinärwesen. Blutentnahme bei Labornagetieren und Kaninchen zu Versuchszwecken.
http://www.bvet.admin.ch/themen/tierschutz/00777/00778/index.html (29.11.2006)
2. CDC issues recommendations for preventing spread of vancomycin resistance. Am J Health Syst Pharm 1995; 52: 1272-1274
3. Klinikleitfaden Intensivmedizin. Klinikleitfaden-online. Urban & Fischer 2000.
http://www2.medizin-online.de/public/html/gufischer/KLF/IVFBI000F/index.html (29.11.2006) 4. Prävention Gefäßkatheter-assoziierter Infektionen. Bundesgesundheitsbl
2002; 45: 907-924 Autorenbeiträge:
5. Ahnefeld FW, Burri C, Halmágyi M. Infusionstherapie II: Parenterale Er-nährung, Klin Anaesth Intensivther Bd 7, Berlin: Springer 1975
6. Bach A, Bohrer H, Motsch J et al. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane poly-mers. J Antimicrob Chemother 1994; 33: 969-978
7. Bach HG, Slowinski ST, Rummel H et al.Punktion und Katheterismus der Vena subclavia. Anaesthesist 1967; 16: 233-237
8. Bassetti S, Hu J, D'Agostino RB jr et al. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protec-tion against catheter infecprotec-tions in vivo. Antimicrob Agents Chemother 2001; 45: 1535-1438
9. Bennet, JA. A Study of Parentalia, with two unpublished letters of Sir Christopher Wren. Annals of Sience 1973; 30: 129-147
10. Berenholtz SM, Pronovost PJ, Lipsett PA et al. Eliminating catheter-rela-ted bloodstream infections in the intensive care unit. Crit Care Med 2004;
32: 2014-2020
11. Blot F; Nitenberg G; Chachaty E et al. Diagnosis of catheter-related bac-teraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999 ; 354: 1071-1077
12. Bolasny BL, Martin CE, Conkle DM. Careful technique with plastic intra-venous catheters. Surg Gynecol Obstet 1971; 132: 1030-1032
13. Brockner J. Intravenous fluid therapy through a catheter inserted percuta-neously in surgigal patients. Acta Chir Scand 1964; 128: 362-364
14. Brun-Buisson C. New technologies and infection control practices to pre-vent intravascular catheter-related infections. Am J Respir Crit Care Med 2001; 164: 1557-1558
15. Burri C, Allgower M. Klinische Erfahrung mit der Messung des ZVDs.
Schweiz Med Wochenschr 1967; 97: 1414-1420
16. Burri C. Kriterien zur Beurteilung hypovolämischer Zustände. Schweiz Z Militärmed 1967; 44: 3
17. Burri C. Der zentrale Venendruck. Erlangen: Pfrimmer 1969
18. Burri C, Allgoewer M. Methodik der Venendruckmessung. Schweiz Med Wochenschr 1966; 96: 624-627
19. Burri C, Kuner E. Bestimmung des zentralen Venendrucks in der Chirur-gie. Med Neuheiten 1966; 72: 81
20. Burri C, Mueller W. Venendruckmessung im Tierversuch und beim chirur-gischen Patienten. Anaesthesist 1966; 15: 132
21. Carratala J, Niubo J, Fernandez-Sevilla A et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with can-cer. Antimicrob Agents Chemother 1999; 43: 2200-2204
22. Cetinkaya R, Odabas AR, Unlu Y et al. Using cuffed and tunnelled cen-tral venous catheters as permanent vascular access for hemodialysis: a prospective study. Ren Fail 2003; 25: 431-438
23. Chaiyakunapruk N, Veenstra D L, Lipsky B A et al. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate com-pared with povidone iodine.Clin Infect Dis 2003; 37(6): 764-771
24. Chiang VW, Baskin MN. Uses and complications of central venous ca-theters inserted in a pediatric emergency department. Pediatr Emerg Care 2000; 16: 230-232
25. Chokr A, Leterme D, Watier D et al. Neither the presence of ica locus, nor in vitro-biofilm formation ability is a crucial parameter for some Sta-phylococcus epidermidis strains to maintain an infection in a guinea pig tissue cage model. Microb Pathog 2007; 42: 94-97
26. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Crit Care 2004; 8:
157-162
27. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1980; 141: 781-786 28. Collin GR. Decreasing catheter colonization through the use of an
anti-septic-impregnated catheter: a continuous quality improvement project.
Chest 1999; 115: 1632-1640
29. Cook D, Randolph A, Kernerman P et al. Central venous catheter re-placement strategies: a systematic review of the literature. Crit Care Med 1997; 25: 1417-1424
30. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322
31. Craus W, Di GA, Tommasino U et al. Totally Implantable Central Venous Access: 15 years' experience in a single unit. J Vasc Access 2001; 2:
161-167
32. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002; 34: 1232-1242
33. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicro-bial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1-8
34. Dettenkofer M, Jonas D, Wiechmann C et al. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravas-cular catheters.Infection 2002; 30(5): 282-285
35. Di Iorio, Lopez T, Procida M et al. Successful use of central venous ca-theter as permanent hemodialysis access: 84-month follow-Up in lucania.
Blood Purif 2001; 19: 39-43
36. Doolas A. Planning intravenous alimentation of surgical patients. Surg Clin North Am 1970; 50: 103-112
37. Edmond MB, Wallace SE, McClish DK et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-244
38. Eggimann P, Harbarth S, Constantin MN et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-1868
39. Eyer S, Brummitt C, Crossley K et al. Catheter-related sepsis: prospec-tive, randomized study of three methods of long-term catheter mainte-nance. Crit Care Med 1990; 18: 1073-1079
40. Fidgor PP. Die Technik des Vena Cava-Katheters. Wien Klin Wschr 1961; 73: 69
41. Fleming CR, McGill DB, Hoffman HN et al. Total parenteral nutrition.
Mayo Clin Proc 1976; 51: 187-199
42. Forssmann W. Die Sondierung des rechten Herzens. Klinische Wochen-schrift 1929; 8: 2085-2087
43. Forssmann W. Selbstversuch. Erinnerungen eines Chirurgen. Düssel-dorf: Droste 1972
44. Fraenkel D, Rickard C, Thomas P et al. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006; 34: 668-675
45. Frank U, Chojnacki T, Dettenkofer M et al. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU. Intensive Care Med 2003; 29: 139
46. Fridkin SK, Pear SM, Williamson TH et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996; 17: 150-158
47. Garland JS, Alex CP, Mueller CD et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107: 1431-1436
48. Gastmeier P, Institut für Medizinische Mikrobiologie und Krankenhaushy-giene MHH. Epidemiologie und Transmission von nosokomialen Infektio-nen auf IntensivstatioInfektio-nen in Deutschland.
http://www.dghm.org/texte/Manuskript%20Gastmeier.pdf (30.11.2006) 49. Gritsch HJ, Ballinger CM. Value of indwelling catheters in intravenous
therapy; description of new needle and catheter set. J Am Med Assoc 1959; 171: 281-286
50. Hall LL, DeLopez OH, Roberts A et al. Technical notes. A procedure for chronic intravenous catheterization in the rabbit. Lab Anim Sci 1974; 24:
79-83
51. Hanna HA, Raad II, Hackett B et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resis-tant bacteremias in critically ill patients. Chest 2003; 124: 1030-1038 52. Hannan M, Juste RN, Umasanker S et al. Antiseptic-bonded central
ve-nous catheters and bacterial colonisation. Anaesthesia 1999; 54: 868-872
53. Harrison N, Langham BT, Bogod DG. Appropriate use of local anaesthe-tic for venous cannulation. Anaesthesia 1992; 47: 210-212
54. Harvey W, Töply R. Die Bewegung des Herzens und des Blutes 1628 / William Harvey. Übers. und erl. von R. Ritter von Töply. Leipzig: J. A.
Barth 1910
55. Hasibeder W. Infektionen an der Intensivstation - Infektionen durch intravaskuläre Katheter.
http://www.intensiv-innsbruck.at/education/infektionen_hasibeder.htm (30.11.2006)
56. Henrickson KJ, Axtell RA, Hoover SM et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromi-sed children by the use of vancomycin/ciprofloxacin/heparin flush solu-tion: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:
1269-1278
57. Hofer S, Schnabel K, Vogelbach P et al. Das "pinch off"-Syndrom: Eine Komplikation bei implantierbaren Kathetersystemen in die Vena
subclavia. Schweiz Med Wochenschr 1997; 127: 1247-1250
58. Humar A, Ostromecki A, Direnfeld J et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31(4): 1001-1007
59. Jaeger K, Zenz S, Juttner B et al. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous
catheter. Ann Hematol 2005; 84: 258-262
60. Koletzko B, Jauch KW, Krohn K et al. Leitlinie Parenterale Ernährung der Deutschen Gesellschaft für Ernährungsmedizin e.V. (DGEM). Aktuel Ernaehr Med 2007; 32: 1-134
61. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004; 9: 207-216
62. Kwong EH, Ramaswamy M, Bauer EA et al. Heat treatment of amphote-ricin b modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits.
Antimicrob Agents Chemother 2001; 45: 2060-2063
63. Langgartner J, Linde HJ, Lehn N et al. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.Intensive Care Med 2004; 30(6):
1081-1088.
64. Leitzmann P, Kramwinkel M, Institut für Ernährungswissenschaft und Zentrum Kinderheilkunde J-L-UG. Anleitung zur parenteralen Ernährung von Kindern und Jugendlichen durch zentralvenöse Zugänge.
http://www.dgem.de/ernaehrungsteams/download/Anleitung_PE_Maerz_
2003-neu.pdf (29.11.2006)
65. Leon C, Ruiz-Santana S, Rello J et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective,
randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004; 30: 1891-1899
66. Levin A, Mason AJ, Jindal KK et al. Prevention of hemodialysis subclavi-an vein catheter infections by topical povidone-iodine. Kidney Int 1991;
40: 934-938
67. Lewis CA, Allen TE, Burke DR et al. Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Soci-ety of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol 1997; 8: 475-479
68. Ljungman P, Hagglund H, Bjorkstrand B et al. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with ind-welling central venous catheters: a randomized, controlled study. Support Care Cancer 1997; 5: 485-488
69. Logghe C, Van OC, D'Hoore W et al. Evaluation of chlorhexidine and sil-ver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997; 37: 145-156
70. Lorente L, Huidobro MS, Martin MM et al. Accidental catheter removal in critically ill patients: a prospective and observational study. Crit Care 2004; 8: 229-233
71. Mack D. Molecular mechanisms of Staphylococcus epidermidis biofilm formation. J Hosp Infect 1999; 43 (Suppl): S113-S125
72. Mack D, Riedewald J, Rohde H et al. Essential functional role of the poly-saccharide intercellular adhesin of Staphylococcus epidermidis in hem-agglutination. Infect Immun 1999; 67: 1004-1008
73. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of in-fection with peripheral intravenous catheters. Gauze, a transparent poly-urethane dressing, and an iodophor-transparent dressing. JAMA 1987;
258: 2396-2403
74. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povi-done-iodine, alcohol, and chlorhexidine for prevention of infection associ-ated with central venous and arterial catheters. Lancet 1991; 338: 339-343
75. Maki DG, Stolz SM, Wheeler S et al. Prevention of central venous cathe-ter-related bloodstream infection by use of an antiseptic-impregnated ca-theter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266 76. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for
identifying intravenous-catheter-related infection. N Engl J Med 1977;
296: 1305-1309
77. Mann TJ, Orlikowski CE, Gurrin LC et al. The effect of the biopatch, a chlorhexidine impregnated dressing, on bacterial colonization of epidural catheter exit sites. Anaesth Intensive Care 2001; 29: 600-603
78. Mason EE. Central venous nutrient - CVN. J Iowa Med Soc 1972; 62:
598-599
79. McKee R, Dunsmuir R, Whitby M et al. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985; 6: 419-425
80. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402
81. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis 2001; 7: 197-199
82. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:
1249-1272
83. Meyers L. Intravenous Catheterization. Am J Nursing 1945; 45: 930-931 84. Murphy LM, Lipman TO. Central venous catheter care in parenteral
nutri-tion: a review. JPEN J Parenter Enteral Nutr 1987; 11: 190-201
85. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the preven-tion of intravascular catheter-related infecpreven-tions. The Hospital Infecpreven-tion Control Practices Advisory Committee, Center for Disease Control and Prevention. Pediatrics 2002; 110: e51
86. Oda T, Hamasaki J, Kanda N et al. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997; 87:
1242-1244
87. Oliver MJ. Acute dialysis catheters. Semin Dial 2001; 14: 432-435 88. Olson ME, Garvin KL, Fey PD et al. Adherence of Staphylococcus
epi-dermidis to biomaterials is augmented by PIA. Clin Orthop Relat Res 2006; 451: 21-24
89. Opderbecke HW, Bardachzi E. Die Verwendung eines Cava-Katheters bei langdauernder Infusionsbehandlung. Dtsch Med Wochenschr 1961;
86: 203-206
90. Osma S, Kahveci SF, Kaya FN et al. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream in-fections in patients in an intensive care unit. J Hosp Infect 2006; 62: 156-162
91. Parienti JJ, du Cheyron D, Ramakers M et al. Alcoholic povidoneiodine to prevent central venous catheter colonization: a randomized unit-cross-over study. Crit Care Med 2004; 32(3): 708-713
92. Pieters PhC, Tisnado J, Mauro MA. Venous Catheters: A Practical Manual. Stuttgart: Thieme 2003
93. Pinneri F, Mazza A, Garzaro L et al. [Temporary emergency cardiac pacing under continuous echocardiographic control. Feasibility and safety of the procedure without using fluoroscopy]. Ital Heart J Suppl 2003; 4: 581-586
94. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177-1184
95. Pronovost P, Needham D, Berenholtz S et al. An Intervention to De-crease Catheter-Related Bloodstream Infections in the ICU. N Engl J Med 2006; 355: 2725-2732
96. Raad II, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colo-nization and bloodstream infections. A randomized, double-blind trial.
The Texas Medical Center Catheter Study Group. Ann Intern Med 1997;
127: 267-274
97. Raad II, Darouiche R, Hachem R et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173: 418-424
98. Raad II, Hachem R, Tcholakian RK et al. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46: 327-332
99. Raad II, Hanna HA. Intravascular catheter-related infections: new hori-zons and recent advances. Arch Intern Med 2002; 162: 871-878
100. Raad II, Hohn DC, Gilbreath BJ et al. Prevention of central venous cathe-ter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-238
101. Raad II, Luna M, Khalil SA et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;
271: 1014-1016
102. Raad II, Sabbagh MF, Rand KH et al. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1992; 15: 13-20
103. Raju TN. The Nobel chronicles. 1956: Werner Forssmann (1904-79);
Andre Frederic Cournand (1895-1988); and Dickinson Woodruff Richards jr (1895-1973). Lancet 1999; 353: 1891
104. Randolph AG, Cook DJ, Gonzales CA et al. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998; 113: 165-171
105. Ranson MR, Oppenheim BA, Jackson A et al. Double-blind placebo con-trolled study of vancomycin prophylaxis for central venous catheter in-sertion in cancer patients. J Hosp Infect 1990; 15: 95-102
106. Reinhart K, Brunkhorst FM, Bone HG et al. Diagnosis and therapy of sepsis. Clin Res Cardiol 2006; 95: 429-454
107. Richet H, Hubert B, Nitemberg G et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive cen-tral-catheter cultures in intensive care unit patients. J Clin Microbiol 1990;
28: 2520-2525
108. Rupp ME, Lisco SJ, Lipsett PA et al. Effect of a second-generation ve-nous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005; 143: 570-580
109. Rupp ME, Ulphani JS, Fey PD et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 1999; 67: 2627-2632 110. Rupp ME, Ulphani JS, Fey PD et al. Characterization of Staphylococcus
epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pa-thogenesis of intravascular catheter-associated infection in a rat model.
Infect Immun 1999; 67: 2656-2659
111. Ruschulte H, Franke M, Gastmeier P et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009;
88(3): 267-272
112. Scalea TM, Sinert R, Duncan AO et al. Percutaneous central venous access for resuscitation in trauma. Acad Emerg Med 1994; 1: 525-521 113. Sesso R, Barbosa D, Leme IL et al. Staphylococcus aureus prophylaxis
in hemodialysis patients using central venous catheter: effect of mupiro-cin ointment. J Am Soc Nephrol 1998; 9: 1085-1092
114. Sheng WH, Ko WJ, Wang JT et al. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in in-tensive care unit patients. Diagn Microbiol Infect Dis 2000; 38: 1-5 115. Sherertz RJ, Ely EW, Westbrook DM et al. Education of
physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132: 641-648
116. Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infec-tion: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641-646
117. Sherertz RJ, Raad II, Belani A et al. Three-year experience with sonica-ted vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76-82
118. Sheth NK, Franson TR, Rose HD et al. Colonization of bacteria on polyvi-nyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983; 18: 1061-1063
119. Shiro H, Muller E, Gutierrez N et al. Transposon mutants of Staphylococ-cus epidermidis deficient in elaboration of capsular polysaccharide/adhe-sin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis 1994; 169: 1042-1049
120. Soifer NE, Borzak S, Edlin BR et al. Prevention of peripheral venous ca-theter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158: 473-477
121. Stephens R, Mythen M, Kallis P et al. Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. Br J Anaesth 2001; 87: 306-308
122. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of de-veloping bacterial resistance to antiseptics and antibiotics used in medi-cal devices. J Antimicrob Chemother 2001; 47: 589-598
123. Tao JH, Fan CS, Gao SE et al. Depression of biofilm formation and anti-biotic resistance by sarA disruption in Staphylococcus epidermidis. World J Gastroenterol 2006; 12: 4009-4013
124. Timsit JF, Farkas JC, Boyer JM et al. Central vein catheter-related throm-bosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114: 207-213
125. Uldall PR, Merchant N, Woods F et al. Changing subclavian haemodialy-sis cannulas to reduce infection. Lancet 1981; 1: 1373
126. Vandecasteele SJ, Peetermans WE, Merckx R et al. Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 2003; 9: 114-119
127. Veenstra DL, Saint S, Saha S et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream in-fection: a meta-analysis. JAMA 1999; 281(3): 261-267
128. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-im-pregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282: 554-560
129. Viale P, Stefani S. Vascular catheter-associated infections: a microbiolo-gical and therapeutic update. J Chemother 2006; 18: 235-249
130. Voegele LD. Subclavian venipuncture for vascular access. South Med J 1980; 73: 1288-1289
131. Waitt C, Waitt P, Pirmohamed M. Intravenous therapy. Postgrad Med J 2004; 80: 1-6
132. Wasan KM, Kennedy AL, Cassidy SM et al. Pharmacokinetics, distribu-tion in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit mo-del: single-dose studies. Antimicrob Agents Chemother 1998; 42: 3146-3152
133. Wenzel RP. Nosocomial candidemia: risk factors and attributable mortali-ty. Clin Infect Dis 1995; 20: 1531-1534
134. Young EM, Commiskey ML, Wilson SJ. Translating evidence into prac-tice to prevent central venous catheter-associated bloodstream infec-tions: a systems-based intervention. Am J Infect Control 2006; 34: 503-506
135. Zakrzewska-Bode A, Muytjens HL, Liem KD et al. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduc-tion of colonizareduc-tion of central venous catheters. J Hosp Infect 1995; 31:
189-193
136. Zimmermann B. Scientificapparatus and laboratory methods: Intravenous tubing for parenteral therapy. Science 1945; 101: 567-568